Methylene Blue: Mitochondrial Electron Carrier with Experimental Nootropic Use
⚡ 60-Second Summary
Methylene blue (MB) is a synthetic phenothiazine compound with a long history as a biological stain and medical drug. It is FDA-approved for the treatment of methemoglobinemia — a condition where hemoglobin cannot release oxygen — and has been used in malaria treatment and as a surgical dye.
Interest in methylene blue as a nootropic or anti-aging supplement centers on its mitochondrial electron carrier function. MB can accept and donate electrons in the mitochondrial electron transport chain, potentially enhancing cellular energy production and acting as an antioxidant at low doses. Human evidence for cognitive or longevity effects is very preliminary.
Methylene blue is a pharmaceutical drug, not a traditional supplement. It has significant drug interactions — particularly with serotonergic drugs — and can cause serotonin syndrome at higher doses. Unregulated supplement products may contain impurities, inappropriate concentrations, or contaminants.
What is Methylene Blue?
MB's mechanism involves acting as a redox mediator — accepting electrons from NADH and donating them to cytochrome c, effectively acting as a cyclic electron shuttle that can bypass complex I and III dysfunction. This may explain its neuroprotective effects in models of mitochondrial disease and neurodegeneration.
MB has also been studied for its antiparasitic properties, antibacterial effects, and as a potential antidepressant MAO inhibitor. The 'low-dose hormesis' hypothesis suggests that very low doses (sub-micromolar) may have cognitive benefits while higher doses become inhibitory. This hormetic dose-response is theoretically interesting but not established in robust human trials.
Evidence-based benefits
Cognitive function / nootropic
A few small human trials and case series suggest possible acute cognitive improvements; evidence is very preliminary and study quality is low.
Mitochondrial support
Mechanistically plausible; no rigorous human RCTs in healthy populations.
Neuroprotection / anti-aging
Animal models and cell studies are extensive; human translation is unproven.
Medical uses (FDA-approved)
Methemoglobinemia treatment (intravenous); ifosfamide encephalopathy; not a supplement indication.
Supplement forms compared
| Form | Typical dose / Bioavailability | Best for | Notes |
|---|---|---|---|
| Pharmaceutical grade (99%+ purity) | 0.5–4 mg/day (very low dose) | Only form worth considering | Industrial-grade or aquarium dye MB contains heavy metal impurities — dangerous |
| USP-grade oral solutions | 0.5–2 mg/kg for medical use | Medical context only | Doses used medically are much higher than proposed nootropic doses |
How much should you take?
- Proposed nootropic doses range from 0.5–4 mg/day — far below medical doses
- Hormesis curve suggests very low doses may be beneficial while higher doses are inhibitory
- No established safe supplemental dose in healthy humans
There is no established safe supplemental dose. Using pharmaceutical-grade MB is essential — industrial-grade or aquarium-use methylene blue contains heavy metals (arsenic, lead, mercury impurities) and should never be ingested. The risk profile is not well characterized at low doses in healthy populations.
Safety and side effects
Common side effects
- Blue discoloration of urine, stool, and mucous membranes at any dose
- Headache, dizziness, nausea
- Serotonin syndrome at higher doses, especially with serotonergic drugs
- Hemolytic anemia at higher doses in G6PD deficiency
Serious risks
Methylene blue is contraindicated with all serotonergic medications due to its MAO inhibitor activity — combining MB with SSRIs, SNRIs, tramadol, linezolid, or other serotonergic drugs risks serotonin syndrome, a potentially life-threatening condition. People with G6PD deficiency must avoid MB as it causes severe hemolytic anemia.
Drug and nutrient interactions
- SSRIs (fluoxetine, sertraline, etc.) — high risk of serotonin syndrome; contraindicated
- SNRIs (venlafaxine, duloxetine) — contraindicated; serotonin syndrome risk
- Tramadol, fentanyl, meperidine — contraindicated with IV MB; risky orally
- Linezolid — both are MAO inhibitors; contraindicated
- St. John's Wort and 5-HTP — serotonergic supplements; avoid combining
- G6PD deficiency — absolute contraindication
Check our free interaction checker for additional combinations.
Who might benefit — and who should use caution
| Most likely to benefit | Use with caution or seek guidance |
|---|---|
| Anyone on serotonergic medications (SSRIs, SNRIs, tramadol) | Absolute contraindication — serotonin syndrome risk |
| Anyone with G6PD deficiency | Absolute contraindication — hemolytic anemia risk |
| Biohackers exploring nootropic protocols | Very preliminary evidence; pharmaceutical-grade only; many unknowns about long-term safety |
| People with mitochondrial disease | Potentially interesting mechanistically; consult specialist; not proven |
Frequently asked questions
Is methylene blue safe to take as a supplement?
It is not classified as a supplement — it is a pharmaceutical drug. At very low doses it appears tolerable in short-term experiments, but the long-term safety in healthy adults is not established, and drug interaction risks are substantial.
Can any methylene blue be used as a supplement?
Only pharmaceutical-grade (99%+ purity, heavy metal free) methylene blue is safe for human consumption. Industrial-grade, aquarium-grade, or lab-grade MB contains toxic impurities.
What is serotonin syndrome?
Serotonin syndrome is a potentially life-threatening condition caused by excess serotonergic activity. Symptoms include agitation, hyperthermia, tachycardia, tremor, and in severe cases, seizures. Methylene blue's MAO inhibitor activity can trigger it when combined with serotonergic drugs.
Why is methylene blue blue?
Its chemical structure includes a phenothiazine ring system that absorbs light in the red spectrum, producing the characteristic blue appearance. It colors urine and stools blue at supplement doses.
Is methylene blue approved by the FDA?
Yes — for treating methemoglobinemia (intravenous) and ifosfamide encephalopathy. It is not approved as a dietary supplement or nootropic.
Related ingredients
CoQ10
Mitochondrial electron carrier with much better-established safety profile
NAD+ Precursors
Mitochondrial energy metabolism support with more clinical evidence
PQQ
Another mitochondrial electron carrier under investigation
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.